IndraLab

Statements

KCNQ1 inhibits IRS-2/PI3K/Akt. 1 / 1

| 1

reach

"In this study, we found that a KCNQ1 selective inhibitor (chromanol 293B) increased the uptake of extracellular glucose and activated the IRS-2/PI3K/Akt pathway in normal and IR HepG2 cells, indicating that KCNQ1 has a pivotal role in regulating insulin signal transduction pathways under both physiological and pathological conditions."

27857189

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

KCNQ1 inhibits IRS-2/PI3K/Akt. 1 / 1

INDRA sources:

Databases

Reading